Contract Research Organization Market revenue to hit USD 108 Billion by 2035, says Research Nester
15 janv. 2024 06h00 HE
|
Research Nester
New York , Jan. 15, 2024 (GLOBE NEWSWIRE) -- The global contract research organization market size is slated to expand at 7% CAGR between 2023 and 2035. The market is poised to garner a revenue of...
Medigene AG to attend at the 42nd Annual J.P. Morgan Healthcare Conference
19 déc. 2023 08h00 HE
|
Medigene AG
Planegg/Martinsried, December 19, 2023. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell...
Zenas BioPharma Strengthens Executive Leadership with Appointment of Jennifer Fox as Chief Business Officer and Chief Financial Officer and Tanya Fischer, M.D., PhD. as Head of R&D and Chief Medical Officer
04 déc. 2023 08h00 HE
|
Zenas BioPharma
WALTHAM, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and...
Single Cell Sequencing Market Size to Reach USD 6,193.01 Million in 2032
30 nov. 2023 03h25 HE
|
Emergen Research
Vancouver, Nov. 30, 2023 (GLOBE NEWSWIRE) -- The global single-cell sequencing market is expected to reach USD 6,193.01 Million by 2032, according to a new report by Emergen Research. Single-cell...
Medigene AG Announces Prioritization of Pipeline and Resource Allocation as well as Extension of Cash Runway
21 nov. 2023 12h05 HE
|
Medigene AG
Lead program MDG1015 on track for CTA/IND approval in 2H 2024Prioritization of pipeline to accelerate the advancement of Medigene’s maturing KRAS-libraryProjected cash runway extended to Q1 2025....
Medigene amends 2023 financial guidance
21 nov. 2023 12h00 HE
|
Medigene AG
Planegg/Martinsried, November 21, 2023 The Executive Management Board of Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the...
Immunology Collaboration and Licensing Agreements Analysis Report 2023
17 nov. 2023 06h13 HE
|
Research and Markets
Dublin, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The "Immunology Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering.Immunology Collaboration and...
Glycomics Market to be Worth USD 3.1 billion by 2031 Globally, at a CAGR of 11.2 % | TMR Report
13 nov. 2023 05h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global glycomics market is projected to flourish at a CAGR of 11.2% from 2023 to 2031....
BioTechnology Innovators Honored in 3rd Annual BioTech Breakthrough Awards Program
08 nov. 2023 08h00 HE
|
BioTech Breakthrough
LOS ANGELES, Nov. 08, 2023 (GLOBE NEWSWIRE) -- BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology...
Medigene presents new data for MDG2011, the first TCR in a novel KRAS library, demonstrating capability of its proprietary E2E Platform to generate multiple enhanced TCR-T therapies against mKRAS G12V A*11
04 nov. 2023 12h00 HE
|
Medigene AG
Planegg/Martinsried, November 4, 2023. Medigene AG (Medigene, the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell...